Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesús Pintor

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|January 29, 2005
Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucomaJesús Pintor
Purinergic Signalling|September 22, 2018
Light-induced ATP release from the lensJesús Pintor
Purinergic Signalling|August 21, 2014
Contact lenses: new devices for nucleotide delivery in ocular pathologiesJesús Pintor
Purinergic Signalling|April 19, 2011
Commentary : Why are such high concentrations of nucleotides in the lens?Jesús Pintor
Journal of Optometry|August 6, 2018
Pharmacology without drugsJesús Pintor
Journal of Optometry|June 19, 2016
Ready for actionGonzalo Carracedo, Jesús Pintor
Cornea|April 25, 2008
Ocular mucin visualization by confocal laser scanning microscopyAssumpta Peral, Jesús Pintor
Experimental Eye Research|May 9, 2012
Focus on molecules: purinergic P2Y(2) receptorAna Guzman-Aranguez, Jesús Pintor
Pharmacology & Therapeutics|January 19, 2007
Melatonin receptors in the eye: location, second messengers and role in ocular physiologyPilar Alarma-Estrany, Jesús Pintor
Experimental Eye Research|May 3, 2015
TRPV4 activation triggers the release of melatonin from human non-pigmented ciliary epithelial cellsHanan Awad Alkozi, Jesús Pintor
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Current Opinion in Investigational Drugs (London, England : 2000)|January 29, 2005
Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucomaJesús Pintor
Purinergic Signalling|September 22, 2018
Light-induced ATP release from the lensJesús Pintor
Purinergic Signalling|August 21, 2014
Contact lenses: new devices for nucleotide delivery in ocular pathologiesJesús Pintor
Purinergic Signalling|April 19, 2011
Commentary : Why are such high concentrations of nucleotides in the lens?Jesús Pintor
Journal of Optometry|August 6, 2018
Pharmacology without drugsJesús Pintor
Journal of Optometry|June 19, 2016
Ready for actionGonzalo Carracedo, Jesús Pintor
Cornea|April 25, 2008
Ocular mucin visualization by confocal laser scanning microscopyAssumpta Peral, Jesús Pintor
Experimental Eye Research|May 9, 2012
Focus on molecules: purinergic P2Y(2) receptorAna Guzman-Aranguez, Jesús Pintor
Pharmacology & Therapeutics|January 19, 2007
Melatonin receptors in the eye: location, second messengers and role in ocular physiologyPilar Alarma-Estrany, Jesús Pintor
Experimental Eye Research|May 3, 2015
TRPV4 activation triggers the release of melatonin from human non-pigmented ciliary epithelial cellsHanan Awad Alkozi, Jesús Pintor
Pageof 11